StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.11−0.03 (-19.40%)

Close on Nov 17, 2026Market cap $5.66MP/E –Yield –

AEON Biopharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AEON Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.64M. For fiscal 2025 it was -$17.31M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.31M–
FY2024Dec 31, 2024-$20.29M–
FY2022Dec 31, 2022-$35.58M–
FY2021Dec 31, 2021-$1.49M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.70M–
Q1 FY2026Mar 31, 2026-$2.64M–
Q4 FY2025Dec 31, 2025-$4.71M–
Q3 FY2025Sep 30, 2025-$2.60M–
Q2 FY2025Jun 30, 2025-$2.09M–
Q1 FY2025Mar 31, 2025-$7.91M–
Q4 FY2024Dec 31, 2024-$621.00K–
Q3 FY2024Sep 30, 2024-$2.96M–
Q2 FY2024Jun 30, 2024-$8.12M–
Q1 FY2024Mar 31, 2024-$8.60M–
Q2 FY2023Jun 30, 2023-$10.09M–
Q1 FY2023Mar 31, 2023-$11.06M–
Q4 FY2022Dec 31, 2022-$8.45M–
Q3 FY2022Sep 30, 2022-$26.56M–
Q2 FY2022Jun 30, 2022-$158.49K–
Q1 FY2022Mar 31, 2022-$411.67K–
Q4 FY2021Dec 31, 2021-$162.63K–
Q3 FY2021Sep 30, 2021-$325.32K–
Q2 FY2021Jun 30, 2021-$452.32K–
Q1 FY2021Mar 31, 2021-$554.52K–

More AEON Biopharma figures

See a number that looks wrong?